Literature DB >> 8700179

The Ames test: the two-fold rule revisited.

N F Cariello1, W W Piegorsch.   

Abstract

Mutagenicity in the Ames assay is evaluated by comparing the number of revertants observed in treated cultures to those in untreated cultures. Often, some form of the '2-fold rule' is employed, whereby a compound is judged mutagenic if a 2-fold or greater increase is seen in a treated culture. In order to understand the underpinnings of this approach, we study some of its statistical properties. We assume that the number of revertants on any plate from a given two-group experiment follows a Poisson distribution and we address the following questions: (1) what is the false-positive error probability of observing at least a doubling of the number of colonies from the control to the treatment group?; (2) if a given mean number of colonies is postulated for a control group, what number of colonies above the observed control mean provides a false-positive rate of 5%? We also present results for question 1 in the case where the number of revertants follows a negative binomial distribution.

Mesh:

Year:  1996        PMID: 8700179     DOI: 10.1016/s0165-1218(96)90044-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 2.  The in vitro toxicology of Swedish snus.

Authors:  Christopher R E Coggins; Mark Ballantyne; Margareta Curvall; Lars-Erik Rutqvist
Journal:  Crit Rev Toxicol       Date:  2012-03-09       Impact factor: 5.635

3.  Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer.

Authors:  Nicole Lecot; Belén Dávila; Carina Sánchez; Marcelo Fernández; Mercedes González; Pablo Cabral; Hugo Cerecetto; Romina Glisoni
Journal:  Polymers (Basel)       Date:  2021-12-25       Impact factor: 4.329

4.  Deviation from additivity in mixture toxicity: relevance of nonlinear dose-response relationships and cell line differences in genotoxicity assays with combinations of chemical mutagens and gamma-radiation.

Authors:  Werner K Lutz; Spyros Vamvakas; Annette Kopp-Schneider; Josef Schlatter; Helga Stopper
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

5.  Nonparametric relevance-shifted multiple testing procedures for the analysis of high-dimensional multivariate data with small sample sizes.

Authors:  Cornelia Frömke; Ludwig A Hothorn; Siegfried Kropf
Journal:  BMC Bioinformatics       Date:  2008-01-27       Impact factor: 3.169

6.  Comparative evaluation of the mutagenicity and genotoxicity of smoke condensate derived from Korean cigarettes.

Authors:  Ha Ryong Kim; Jeong Eun Lee; Mi Ho Jeong; Seong Jin Choi; Kyuhong Lee; Kyu Hyuck Chung
Journal:  Environ Health Toxicol       Date:  2015-12-13

7.  Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.

Authors:  Masamitsu Honma; Airi Kitazawa; Alex Cayley; Richard V Williams; Chris Barber; Thierry Hanser; Roustem Saiakhov; Suman Chakravarti; Glenn J Myatt; Kevin P Cross; Emilio Benfenati; Giuseppa Raitano; Ovanes Mekenyan; Petko Petkov; Cecilia Bossa; Romualdo Benigni; Chiara Laura Battistelli; Alessandro Giuliani; Olga Tcheremenskaia; Christine DeMeo; Ulf Norinder; Hiromi Koga; Ciloy Jose; Nina Jeliazkova; Nikolay Kochev; Vesselina Paskaleva; Chihae Yang; Pankaj R Daga; Robert D Clark; James Rathman
Journal:  Mutagenesis       Date:  2019-03-06       Impact factor: 3.000

8.  Microbial Mutagenicity Assay: Ames Test.

Authors:  Urvashi Vijay; Sonal Gupta; Priyanka Mathur; Prashanth Suravajhala; Pradeep Bhatnagar
Journal:  Bio Protoc       Date:  2018-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.